Patient reported outcomes of new brand-generic product of Teriflunomide (TEBAZIO®) in patients with relapsing-remitting multiple sclerosis: Preliminary analysis

Saved in:
Bibliographic Details
Published inJournal of the neurological sciences Vol. 429; p. 118097
Main Authors Abolfazli, Roya, Nabavi, Seyed Massood, Azimi, Amir Reza, Nahayati, Mohammad Ali, Gharegozli, Koroush, Ghazaeian, Monireh, Shahrokhi, Shahrzad, Samadzadeh, Sara
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.10.2021
Online AccessGet full text

Cover

More Information
ISSN:0022-510X
1878-5883
DOI:10.1016/j.jns.2021.118097